TipRanks
Go Ultimate55% OFF

Immunotech Laboratories (IMMB) Financial Statements

Immunotech Laboratories Financial Overview

Immunotech Laboratories's market cap is currently $114.99K. The company's EPS TTM is ―; its P/E ratio is -0.22; Immunotech Laboratories has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 16
Income Statement
Total Revenue$ 0.00
Gross Profit$ -305.55K
Operating Income$ -470.36K
EBITDA$ -454.01K
Net Income$ -493.03K
Balance Sheet
Cash & Short-Term Investments$ 14.29K
Total Assets$ 10.53M
Total Debt$ 2.42M
Net Debt$ 2.40M
Total Liabilities$ 5.73M
Stockholders' Equity$ 4.80M
Cash Flow
Free Cash Flow$ -31.16K
Operating Cash Flow$ -31.16K
Investing Cash Flow$ 16.35K
Financing Cash Flow$ 24.05K

Currency in USD

Immunotech Laboratories Earnings and Revenue History

-600K-400K-200K00 %0.4 %0.8 %1.2 %EarningsProfit Margin2016RevenueEarningsProfit Margin

Immunotech Laboratories Debt to Assets

04M8M12M53 %54 %55 %56 %LiabilitiesDebt to Assets2016AssetsLiabilitiesDebt to Assets

Immunotech Laboratories Cash Flow

-40K-30K-20K-10K010K20K30K2016OperatingInvestingFinancing

Immunotech Laboratories Forecast EPS vs Actual EPS